CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Beijing Aosaikang Pharmaceutical Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Beijing Aosaikang Pharmaceutical Co Ltd
No.699 Kejian Road
Jiangning Science Park
Phone: +86 2552292222p:+86 2552292222 NANJING, JNG  211112  China Ticker: 002755002755

Business Summary
BEIJING AOSAIKANG PHARMACEUTICAL CO., LTD., formerly Beijing New Oriental Star Petrochemical Engineering Co., Ltd., is a China-based company mainly engaged in pharmaceutical manufacturing business. The Company produces proton pump inhibitor injections through its subsidiary Jiangsu Aosaikang Pharmaceutical Co., Ltd.
(Source: 10KSB40)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/202412/31/2023Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board QingcaiChen 63 2/17/2022 2/19/2019
Chief Financial Officer TaoHan 37 2/19/2019 2/19/2019
General Manager, Secretary of the Board, Director JingfeiMa 34 2/18/2022 9/30/2021
6 additional Officers and Directors records available in full report.

General Information
Number of Employees: 979 (As of 12/31/2023)
Outstanding Shares: 928,160,351 (As of 9/30/2024)
Shareholders: 18,658
Stock Exchange: SHE
Fax Number: +86 2552169333


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, December 3, 2024